Back to search

Article

Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvement

2016-04-22

Abstract excerpt

Advances in genetic engineering have made it possible to reprogram individual immune cells to express receptors that recognise markers on tumour cell surfaces. The process of re-engineering T cell lymphocytes to express Chimeric Antigen Receptors (CARs), and then re-infusing the CAR-modified T cells into patients to treat various cancers is referred to as CAR T cell therapy. This therapy is being explored in clin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
628aa109-b24b-5c82-84be-56f7da98547d
DOI
10.1101/049908
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Toxicity Management in CAR T cell therapy for B-ALL: Mathematical modelling as a new avenue for improvementDOI 10.1101/049908
Select a neighboring publication to make it the new centre.